Viral N 6-methyladenosine upregulates replication and pathogenesis of human respiratory syncytial virus

92Citations
Citations of this article
92Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

N6-methyladenosine (m6A) is the most prevalent internal modification of mRNAs in most eukaryotes. Here we show that RNAs of human respiratory syncytial virus (RSV) are modified by m6A within discreet regions and that these modifications enhance viral replication and pathogenesis. Knockdown of m6A methyltransferases decreases RSV replication and gene expression whereas knockdown of m6A demethylases has the opposite effect. The G gene transcript contains the most m6A modifications. Recombinant RSV variants expressing G transcripts that lack particular clusters of m6A display reduced replication in A549 cells, primary well differentiated human airway epithelial cultures, and respiratory tracts of cotton rats. One of the m6A-deficient variants is highly attenuated yet retains high immunogenicity in cotton rats. Collectively, our results demonstrate that viral m6A methylation upregulates RSV replication and pathogenesis and identify viral m6A methylation as a target for rational design of live attenuated vaccine candidates for RSV and perhaps other pneumoviruses.

Cite

CITATION STYLE

APA

Xue, M., Zhao, B. S., Zhang, Z., Lu, M., Harder, O., Chen, P., … Li, J. (2019). Viral N 6-methyladenosine upregulates replication and pathogenesis of human respiratory syncytial virus. Nature Communications, 10(1). https://doi.org/10.1038/s41467-019-12504-y

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free